Q1 2025 Earnings Conference Call May 12, 2025 8:30 AM ETCompany ParticipantsZack Armen - Head of Investor RelationsGaro Armen ...

A study of more than 100 patients found that immunotherapy can cure a rare type of cancer in various tumor sites without ...

The Fort Hill boys defeated rival Allegany, 4-1, on Wednesday, and the Campers’ girls swept the Sentinels, 5-0, to split the match. Fort Hill (5-5) won both boys singles matches handily, as Gunner ...

Fans of Grey's Anatomy character, Levi Schmitt, played by Jake Borelli, will be happy to know the doctor is back helping out ...

Film Independent Members, you and a guest are invited to join us for a theatrical screening of Love Me, featuring a Q&A with ...

With a 95% retention rate for nurse residents completing the program and a 100% 2-year post-hire retention rate, these initiatives ensure a stable and well-trained workforce.

Yelena Y. Janjigian, MD, discusses how to manage the potential adverse events of pembrolizumab when using the recently approved combination of pembrolizumab plus trastuzumab and chemotherapy.

New research disentangles the risks for acute kidney injury related to CAR T-cell treatment in non-Hodgkin lymphoma, ...

Scientific Advisory Board (SAB) of clinical and scientific experts to advise it on its products designed to maximize the ...

Larry Hogan speaks to members of the media at the AstraZeneca facility in Gaithersburg, Md., on Aug. 26, 2024. Larry Hogan ...

A new study shows promising results for treating certain cancers with immunotherapy and completely avoiding surgery, ...